References
Chirigos, M.A., Pearson, J.W., Pryor, J.: Augmentation of chemically induced remission of a murine leukemia by a chemical immuno adjuvant. Cancer Res.33:2615, 1973
Renoux, F., Renoux, M.: Levamisole inhibits and sures a solid malignant tumour and its pulmonary metastases. Nature [New Biol]240:217, 1972
Tripodi, D., Parks, L.C., Brugmans, J.: Drug induced restoration of cutaneous delayed hypersensitivity in anergic patients with cancer. New Engl. J. Med.289:354, 1973
Sampson, D., Lui, A.: The effect of levamisole on cell mediated immunity and suppressor cell function. Cancer Res.36:952, 1976
Verhaegen, H., Dewee, J., De Cock, W., Herhuiggen, F.: Levamisole and the immune response. New Engl. J. Med.289:1148, 1973
Webster, D.J.J., Hughes, L.E.: Levamisole. Lancet1:389, 1975
Shibata, H.R., Jerry, L.M., Lewis, M.G., Mansell, P.W., Capek, A., Marquis, G.: Immunotherapy of human malignant melanoma with irradiated tumor cells, oral BCG and levamisol. Ann. N.Y. Acad. Sci.277:355, 1976
Williams, I.A.: Levamisole and agranulocytosis. Lancet1:1080, 1976
Rosenthal, M., Trabert, W., Muller, W.: Complications of cancer immunotherapy with levamisole. Lancet (in press)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lewis, M.G. Invited commentary. World J. Surg. 1, 603–604 (1977). https://doi.org/10.1007/BF01556186
Issue Date:
DOI: https://doi.org/10.1007/BF01556186